| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.385 | 3.947 | 6.659 | 9.360 | 18.640 | 19.810 | 22.460 | 24.647 |
| Total Income - EUR | - | - | 1.385 | 3.947 | 6.659 | 9.360 | 18.640 | 19.810 | 22.460 | 24.647 |
| Total Expenses - EUR | - | - | 246 | 1.003 | 523 | 3.830 | 4.887 | 8.744 | 7.562 | 6.387 |
| Gross Profit/Loss - EUR | - | - | 1.139 | 2.944 | 6.136 | 5.530 | 13.754 | 11.066 | 14.898 | 18.260 |
| Net Profit/Loss - EUR | - | - | 1.097 | 2.825 | 5.936 | 5.262 | 13.239 | 10.561 | 12.872 | 15.187 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mianco Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 1.316 | 3.966 | 6.227 | 11.377 | 19.491 | 23.910 | 37.775 | 16.634 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 566 |
| Cash | - | - | 1.316 | 3.966 | 6.227 | 11.377 | 19.491 | 23.910 | 37.775 | 16.069 |
| Shareholders Funds | - | - | 1.141 | 3.945 | 5.978 | 11.126 | 19.267 | 23.804 | 36.604 | 15.802 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 235 | 20 | 249 | 251 | 224 | 105 | 1.171 | 832 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mianco Medica Srl